Hussain, A.; Asare-Amankwah, Y.; Qureshi, S.; Thornton, M.J.; Palmer, T.M.; Bolanle, I.O.; Wood, I.C.; Turner, N.A.; Porter, K.E.; Tedder, A.;
et al. Defining the miRnome of Saphenous Vein Smooth Muscle Cells from Patients with Type 2 Diabetes Mellitus. Diabetology 2024, 5, 178-189.
https://doi.org/10.3390/diabetology5020014
AMA Style
Hussain A, Asare-Amankwah Y, Qureshi S, Thornton MJ, Palmer TM, Bolanle IO, Wood IC, Turner NA, Porter KE, Tedder A,
et al. Defining the miRnome of Saphenous Vein Smooth Muscle Cells from Patients with Type 2 Diabetes Mellitus. Diabetology. 2024; 5(2):178-189.
https://doi.org/10.3390/diabetology5020014
Chicago/Turabian Style
Hussain, Alisah, Yaw Asare-Amankwah, Shehryar Qureshi, M. Julie Thornton, Timothy M. Palmer, Israel O. Bolanle, Ian C. Wood, Neil A. Turner, Karen E. Porter, Andrew Tedder,
and et al. 2024. "Defining the miRnome of Saphenous Vein Smooth Muscle Cells from Patients with Type 2 Diabetes Mellitus" Diabetology 5, no. 2: 178-189.
https://doi.org/10.3390/diabetology5020014
APA Style
Hussain, A., Asare-Amankwah, Y., Qureshi, S., Thornton, M. J., Palmer, T. M., Bolanle, I. O., Wood, I. C., Turner, N. A., Porter, K. E., Tedder, A., & Riches-Suman, K.
(2024). Defining the miRnome of Saphenous Vein Smooth Muscle Cells from Patients with Type 2 Diabetes Mellitus. Diabetology, 5(2), 178-189.
https://doi.org/10.3390/diabetology5020014